US 10098878
HIF-2α inhibitors for treating iron overload disorders
granted A61KA61K31/085A61K31/09
Quick answer
US patent 10098878 (HIF-2α inhibitors for treating iron overload disorders) held by The Board of Regents of the University of Texas System expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/085, A61K31/09, A61K31/10, A61K31/145